Dyslipidemias
Showing 26 - 50 of 907
Dyslipidemias, Obesity Trial in Storrs (Milk Polar Lipid-Rich Dairy Powder, Dairy Powder)
Not yet recruiting
- Dyslipidemias
- Obesity
- Milk Polar Lipid-Rich Dairy Powder
- Dairy Powder
-
Storrs, ConnecticutUniversity of Connecticut
Jan 18, 2023
Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Amman
Not yet recruiting
- Dyslipidemias
- Atherosclerotic Cardiovascular Disease
-
Amman, Jordan
- +1 more
Nov 23, 2022
PreDiabetes, Abdominal Obesity, Hypertension Trial in Beijing (Berberine plus lifestyle intervention, Placebo plus lifestyle
Not yet recruiting
- PreDiabetes
- +3 more
- Berberine plus lifestyle intervention
- Placebo plus lifestyle intervention
-
Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences, National Ce
Mar 6, 2023
Coronary Artery Disease, Dyslipidemias Trial in Yongin (a high dose of statin/ezetimib)
Recruiting
- Coronary Artery Disease
- Dyslipidemias
- a high dose of statin/ezetimib
-
Yongin, Gyeonggi-do, Korea, Republic ofYongin Severance Hospital
Jun 14, 2023
Obesity, Prediabetic State, Dyslipidemias Trial (INOSITOLS, CELLULOSE)
Not yet recruiting
- Obesity
- +3 more
- INOSITOLS
- CELLULOSE
- (no location specified)
Jan 19, 2023
Dyslipidemias, Non-Alcoholic Fatty Liver Disease Trial in San Antonio (LY3885125, Placebo)
Recruiting
- Dyslipidemias
- Non-Alcoholic Fatty Liver Disease
- LY3885125
- Placebo
-
San Antonio, TexasWorldwide Clinical Trials, Early Phase Services LLC
Aug 18, 2023
Metabolic Diseases, Immune System Disorder, Dyslipidemias Trial in Nanjing (Phytosterol-rich Wheat and Corn Germ Blended Oil,
Active, not recruiting
- Metabolic Diseases
- +4 more
- Phytosterol-rich Wheat and Corn Germ Blended Oil
- Peanut oil
-
Nanjing, Jiangsu, ChinaZhongda Hospital, Affiliated to Southeast University
Oct 2, 2023
Epicardial Fat Thickness in Children With Familial Dyslipidemia
Not yet recruiting
- Dyslipidemia
- echoCARDIOGRAPHY
- (no location specified)
Oct 22, 2023
OLOMAX for Blood Pressure and Low-density Lipoprotein
Recruiting
- Hypertension
- Dyslipidemias
- Olmesartan Medoxomil/ Amlodipine Besylate/ Rosuvastatin Ca
-
Seoul, Korea, Republic ofSeoul St.Mary's Hospital
Dec 13, 2022
Cardiovascular Diseases, Atherosclerosis, Dyslipidemias Trial (Digitally-enabled Multifaceted Quality Improvement Intervention,
Not yet recruiting
- Cardiovascular Diseases
- +2 more
- Digitally-enabled Multifaceted Quality Improvement Intervention
- Usual care
- (no location specified)
Nov 14, 2022
Cardiovascular Diseases, Heart Diseases, Cerebrovascular Disease Trial in Astros (Patient counselling)
Recruiting
- Cardiovascular Diseases
- +9 more
- Patient counselling
-
Astros, GreeceAstros Health Care Center
Oct 30, 2023
Dyslipidemias, Stroke, Acute Ischemic Trial in Ansan, Seoul (combination of high-dose rosuvastatin and ezetimibe, high-dose
Recruiting
- Dyslipidemias
- Stroke, Acute Ischemic
- combination of high-dose rosuvastatin and ezetimibe
- high-dose rosuvastatin single administration
-
Ansan, Gyeonggi-do, Korea, Republic of
- +2 more
May 22, 2023
Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)
Not yet recruiting
- Dyslipidemias
- +4 more
- Combination Therapy
- +5 more
- (no location specified)
Aug 22, 2023
Dyslipidemias Trial in Seoul (Drug: CKD-391, QD, PO)
Not yet recruiting
- Dyslipidemias
- Drug: CKD-391, QD, PO
-
Seoul, Gangseo-gu, Korea, Republic ofBumin Hospital(Seoul)
Nov 22, 2022
Metabolic Syndrome, High Blood Pressure, High Cholesterol Trial in Wilrijk (Tensiofytol, Cholesfytol NG, Placebo)
Recruiting
- Metabolic Syndrome
- +4 more
- Tensiofytol
- +2 more
-
Wilrijk, BelgiumUAntwerp, NatuRA
Nov 22, 2022
Coronary Artery Disease, Coronary Heart Disease, Hypertension Trial in Philadelphia (Gamification Intervention)
Not yet recruiting
- Coronary Artery Disease
- +6 more
- Gamification Intervention
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Sep 3, 2022
Different Equations to Accurately Calculate LDL Cholesterol
Active, not recruiting
- Dyslipidemias
- Lipid Disorder
- no intervention, Serum LDL cholesterol calculation
-
Bron, FranceLaboratoire de Biologie Médicale Multi Sites, Centre de Biologie
Oct 24, 2022
Status of Dyslipidemia Following Administration of Statin and
Recruiting
- Dyslipidemias
- Statin+Ezetimibe compound
-
Seoul, Korea, Republic ofKorea University Guro Hospital
Nov 7, 2022
Insulin Resistance, Hyperinsulinemia, Dyslipidemias Trial in New York (drug, device, diagnostic test, dietary supplement)
Recruiting
- Insulin Resistance
- +2 more
- Alpelisib 150 mg [Piqray], 2 overencapsulated tablets (total: 300 mg)
- +4 more
-
New York, New YorkColumbia University Irving Medical Center
Feb 3, 2023
Cardiovascular Diseases, Dyslipidemias Trial in Yinchuan (Walnuts 30 grams, Walnuts 60 grams)
Completed
- Cardiovascular Diseases
- Dyslipidemias
- Walnuts 30 grams
- Walnuts 60 grams
-
Yinchuan, Ningxia, ChinaYi Zhao
Aug 8, 2022
PreDiabetes, Obesity, Dyslipidemias Trial in Thessaloniki (Crocus Kozanis, Placebo of Crocus Kozanis, Metformin)
Recruiting
- PreDiabetes
- +2 more
- Crocus Kozanis
- +2 more
-
Thessaloniki, GreeceUnit of Paediatric Endocrinology and Metabolism, 2nd Department
Oct 11, 2022
Dyslipidemias, Hypertension Trial in Daegu (Rosuampin 10/5mg, Rosuampin 20/5mg, Amlodipine/Atorvastatin 5/20mg)
Completed
- Dyslipidemias
- Hypertension
- Rosuampin 10/5mg
- +2 more
-
Daegu, Korea, Republic ofDaegu Catholic Univ. Medical Center
Oct 10, 2022
Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Seoul (Pitavastatin, Pitavastatin plus Ezetemibe, Atorvastatin)
Not yet recruiting
- Dyslipidemias
- Atherosclerotic Cardiovascular Disease
- Pitavastatin
- +2 more
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jan 29, 2023